Fundz

Kardigan Raises $254 Million Series B to Advance Late-Stage Portfolio of Personalized Cardiovascular Medicines with new investors including Fidelity Management & Research and T. Rowe Price.

PUBLIC · KARDOct 14, 2025

Amount Raised

$254 Million

Round Type

Series B

South San FranciscoBiotechnologyHealth Careresearch

Investors

T. Rowe Price Investment Management, Inc.accounts advised by T. Rowe Price Investment ManagementPerceptive AdvisorsSequoia HeritageARCH Venture PartnersT. Rowe Price Investment ManagementFidelity Management & Research Company

Description

Kardigan, a heart health company, announced the closing of a $254 million Series B financing to advance programs targeting severe heart conditions. New investors include Fidelity Management & Research and T. Rowe Price, alongside ARCH Venture Partners and Sequoia Heritage. The funds will support the development of treatments for dilated cardiomyopathy and acute severe hypertension

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Kardigan that raised within 45 days of this round, from Fundz verified event records.

  • Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
  • Hepta raised $6.7M (Seed) on November 5, 2025.
  • AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
  • Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
  • Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
  • Grail raised $325M (Post-IPO Equity) on October 20, 2025.

Who to call at Kardigan, and when

A new round usually means Kardigan is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kardigan raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kardigan, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kardigan. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kardigan

Location

131 Oyster Point Blvd

South San Francisco, California, United States

About

Kardigan is a patient-driven heart health company that is modernizing cardiovascular drug development to deliver medicines that move patients beyond symptom management to functional cures. By matching critical disease drivers with treatment responders identified in clinical trials, Kardigan is developing a portfolio of medicines that modify the underlying cardiovascular disease pathophysiology to get patients closer to the cures they deserve.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kardigan raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKaoru N., Vice President, CMC Quality hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kardigan's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Kardigan raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.